Novartis Looking for Constructive Ways To Bring Down Drug Costs in US

In an interview with German-language outlet Neue Zuercher Zeitung, Novartis CEO Vas Narasimhan said the company is exploring ways to remove or minimize the drug price gap between the U.S. and its other markets in similarly developed countries.

Scroll to Top